Metformin (1,1-dimethylbiguanide; MET) is used in the treatment of type 2 diabetes mellitus. MET's antihyperglycemic action depends at least in part on its inhibitory effect on hepatic gluconeogenesis. As to gluconeogenesis from amino acids (e.g. L-alanine), this is associated with an inhibition of L-alanine uptake into hepatocytes. Since this uptake is mediated by an electrogenic transport mechanism, the aim of the present study was to investigate whether MET has an influence on the liver cell membrane potential which might explain its inhibitory effect on L-alanine uptake. The experiments were performed in vivo in anesthetized rats and in vitro using superfused mouse liver slices with the conventional microelectrode technique. In vivo, MET (160 mg/kg intraperitoneally (i.p.)) significantly depolarized (dV) the liver cell membrane by 6 mV. MET (1 mmol/ l) also depolarized the liver cell membrane in vitro (e.g. 15 min after start of superfusion: dV = 8 mV). MET's effect was at least partly reversible. Glucagon (10 37 mol/l), which hyperpolarized the liver cell membrane, abolished MET's effect. Further, the MET-induced depolarization was completely absent during superfusion with low Cl 3 ([Cl 3 ] = 27 mmol/l) medium, and significantly attenuated by the Cl 3 channel blocker NPPB (25 Wmol/l). While MET's effect was only somewhat attenuated by blockade of the Na /K /2Cl 3 cotransporter or by superfusion with (HCO 3 3 -free) HEPES buffer, the carboanhydrase blocker acetazolamide (1 mmol/l) or blockade of the HCO 3 3 /Cl 3 exchanger by DIDS (100 Wmol/l), which, however, also blocks Cl 3 channels, abolished its effect. The depolarization of the liver cell membrane by MET was unaffected by a blockade of K channels with Ba 2 , a blockade of the Na /K pump or superfusion with low Na medium ([Na ] = 26 mmol/l). According to these results, the MET-induced depolarization of the liver cell membrane could be due to an activation of the Cl 3 /HCO 3 3 exchanger and thus depend on intracellular HCO 3 3 formation. This activation could then lead to a disturbance of the equilibrium between intra-and extracellular Cl 3 and therefore to an enhanced Cl 3 efflux via Cl 3 channels. It is plausible that the depolarizing effect induced by MET is associated with its inhibitory effect on gluconeogenesis by inhibiting uptake of L-alanine and other amino acids into hepatocytes. ß
Introduction
The biguanide metformin (1,1-dimethylbiguanide; MET) is used as an orally active antihyperglycemic drug in the treatment of human type 2 diabetes mellitus [1] . In contrast to another group of orally e¡ective antidiabetics, the sulfonylureas, which act mainly by enhancing insulin secretion from pancreatic L cells, the mechanism of MET's antihyperglycemic action remains controversial [2] . While part of MET's antihyperglycemic e¡ect may depend on reduced intestinal glucose absorption [3] , its main action seems to be due to improving insulin sensitivity in peripheral insulin target tissues and suppressing hepatic glucose output [1, 2] .
Apart from MET inhibiting hepatic gluconeogenesis and hence hepatic glucose output by activation of pyruvate kinase [4, 5] , MET also appears to reduce the supply of gluconeogenic substrates, such as L-lactate or L-alanine. A recent study suggested that the inhibitory e¡ect of MET on gluconeogenesis from L-lactate is secondary to an inhibition of hepatic L-lactate uptake [6] , which is mainly mediated by a carrier-mediated transport system [7, 8] . Further, numerous studies suggest that the inhibitory e¡ect of MET and of other biguanides on hepatic gluconeogenesis is also secondary to an inhibition of L-alanine uptake into liver cells [9^11] .
Since this uptake is mediated by an electrogenic Na -coupled transport mechanism [12^16] and therefore depends on the membrane potential, the ¢rst aim of the present study was to investigate whether MET a¡ects the hepatic membrane potential. As the membrane potential was reduced by MET, additional experiments aimed at clarifying the ionic mechanisms underlying this e¡ect. Finally, we wanted to ¢nd out whether MET's e¡ect on the liver cell membrane potential is counteracted by glucagon which has been shown to hyperpolarize liver cells [17, 18] . The experiments were performed under in vivo conditions in anesthetized rats and under in vitro conditions using superfused mouse liver slices with the conventional microelectrode technique.
Research design and methods

In vivo experiments
Animals and maintenance
Adult male Sprague^Dawley rats (OFA; BRL, Fu « llinsdorf, Switzerland) with an approximate body weight of 250 g were used for the experiments. Rats were fed ad libitum with a diet containing 18% fat, 46% carbohydrate and 13% protein [19] . Rats were adapted to this diet for at least 2 weeks and had ad libitum access to food and water until the experiment.
Experimental protocol
Rats were injected intraperitoneally (i.p.) with MET (160 mg/kg (1 mmol/kg)) made up with distilled water to yield an isotonic solution. Injection of 0.9% NaCl served as control. Rats were anesthetized with a mixture of ketamine and xylazine approx. 20 min after the injection. Ten minutes later, i.e. 30 min after the injection of MET or NaCl, the liver cell membrane potential was measured in the left lateral liver lobe as described before [20, 21] . Brie£y, the liver was exposed by laparotomy and ¢xed with a nictating forceps after Demarres to prevent movements of the liver lobe due to respiration. The upper limb of this forceps is open, allowing puncturing of liver cells by the microelectrode.
Super¢cial liver cells on the parietal surface of the liver were punctured with the microelectrode to measure the liver cell membrane potential. The reference electrode was placed in the abdominal cavity ¢lled with Krebs^Henseleit solution.
In vitro experiments
Animals and maintenance
Adult female mice (NMRI; BRL) with a body weight of 30^50 g were used for the experiments. Mice were fed the same diet and handled as described above for rats.
Liver slice preparation, maintenance and
temperature control Mice were killed by cervical dislocation and the median lobe of the liver was removed quickly and placed on gauze moistened with modi¢ed KrebsĤ enseleit bicarbonate bu¡er ( Table 1 ). The liver lobe was ¢xed by applying slight pressure with a glass microscope slide while preparing liver slices (5U5 mm; thickness about 1 mm) with a scalpel blade. After incubation in oxygenated (95% O 2 , 5% CO 2 ) control bu¡er (Table 1 ; 37³C), the liver slices were placed in an acrylic superfusion chamber with the encapsulated uncut surface of the liver slice upward. All microelectrode impalements were of super-¢cial cells on the uncut surface. Viability of this liver slice preparation has been evaluated previously by Wondergem and Castillo [22] who measured similar membrane potentials using superfused mouse liver slices or mouse hepatocytes in primary monolayer culture prepared from whole liver. The liver slices were superfused at a rate of about 12 ml/min with oxygenated bu¡er ( Table 1) .
The composition of the bu¡er solutions used is shown in Table 1 . All bu¡er solutions were equiosmotic. When MET, ouabain or BaCl 2 was added to the solutions, the NaCl concentration was reduced accordingly (by 0.5 mmol/l or 7.5 mmol/l, respectively). The measured osmolality of the bu¡er solutions was 288 þ 1 mosmol/l.
Part of the experiments were performed with superfusion solutions with a reduced Na (approx. 26 mmol/l) concentration. In this case, NaCl was replaced equiosmotically with choline chloride. To investigate the in£uence of bicarbonate on the depolarizing e¡ect of metformin, a bicarbonate-free superfusion solution bu¡ered with N-[2-hydroxyethyl]piperazine-NP-[2-ethanesulfonic acid] (HEPES) was used. A similar bicarbonate-free bu¡er solution with a reduced Cl 3 (approx. 27 mmol/l) concentration was also used. NaCl was replaced with sodium D-gluconate and the concentration of CaCl 2 was increased to 10 mmol/l to account for Ca 2 chelating by gluconate. In all experiments, the bu¡er temperature was maintained at 37³C and monitored continuously with a thermistor (Ebro CTA 1220; Ingoldstadt, Germany).
Standard experimental protocol
Eight liver slices from at least two mice were used for each experimental condition. After preparation of the liver slices, slices were kept in warm oxygenated control bu¡er until use. After transfer to the superfusion chamber, the liver cell membrane potential was measured after 5 and 10 min. Then, the superfusion solutions were switched to the respective experimental solutions and subsequently, the membrane potential was measured in 3 min intervals. At each time point, the membrane potential was measured twice. The mean of these two values was used for the statistical evaluation of the results (see below). When the in£uence of various blockers (see below) on the depolarizing e¡ect of metformin on the liver cell membrane was investigated, the respective blocker was added to both the control and the experimental solutions.
General procedure
Fabrication of open tip microelectrodes
Open tip microelectrodes were drawn in a horizontal puller (Sachs-Fleming Micropipette Puller PC-84; Sutter Instrument, San Raphael, CA, USA) from micro¢lament glass capillaries (1.5 mm o.d., 0.86 mm i.d.; A-M Systems, Everett, WA, USA). Pipettes were ¢lled with KCl (0.5 mol/l).
Measurement of membrane potential (V m )
The microelectrode was connected by an Ag-AgCl half-cell to a high input impedance preampli¢er (10 13 6; Biologic VF 180; Echirolles, France). For the in vivo experiments, the reference electrode (Ag-AgCl) was placed in the abdominal cavity ¢lled with KrebsĤ enseleit solution. In the in vitro setup, the reference electrode was connected by an Ag-AgCl half-cell to the tissue chamber by an agar (4% in Krebs^Henseleit bu¡er) bridge.
Voltage was measured with a digital voltmeter and an oscilloscope (Kikusui COS 5020 TM; Kawasaki City, Japan) and recorded on a two-channel recorder (Rikadenki B-281-L; Kogyo, Japan). Criteria for valid micropipette impalements of liver cell were: (1) a rapid de£ection of the voltage trace on advancing the microelectrode into the liver slice; (2) a stable voltage trace within 2 mV for at least 10 s; (3) return of the voltage trace to within 2 mV of the baseline when the microelectrode was withdrawn. Resistance of open tip microelectrodes (20^50 M6) was measured once before every impalement by passing AC pulses (I = 1 nA; frequency 1000 Hz).
In the in vivo setup, the membrane potential of ¢ve liver cells was measured, and the mean of these ¢ve values was calculated. Only one such mean was obtained from each animal. The mean coe¤cient of variation for the membrane potential measured in di¡erent cells of a liver lobe was 4.2 þ 0.5%. In the in vitro experiments, the membrane potential was measured twice at each time point. The mean of these two values was used for the statistical evaluation of the results (see below).
Chemicals used
MET, acetazolamide, 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB), 4,4P-diisothiocyanatostilbene-2,2P-disulfonic acid (DIDS), bumetanide, HEPES and ouabain were all from Sigma (Buchs, Switzerland). Glucagon was from Novo Nordisk (Ku « snacht, Switzerland), and BaCl 2 from Siegfried (Zo¢ngen, Switzerland).
Statistical evaluation
All values are presented as mean þ standard error of the mean (x þ S.E.). As mentioned, the membrane potential of two liver cells was measured at each individual time point in the in vitro setup. The mean of these two values was used for the statistical analysis. Similarly, the membrane potential of ¢ve liver cells was measured in the in vivo setup in each rat. The mean of these ¢ve values was then used for further analysis.
When investigating the time course of the hyperpolarizing e¡ect of MET or glucagon, repeated measures ANOVA was used. Di¡erences in the hyperpolarizing e¡ect observed under di¡erent conditions, i.e. di¡erences in the membrane potential measured with the experimental solution compared with the respective control medium, were evaluated using the unpaired Student's t-test, or ANOVA with the Student^Newman^Keuls post hoc test if more than two groups were compared. In all cases, a P value 6 0.05 was considered signi¢cant.
Results
In vivo experiments
The membrane potential was measured 30 min after i.p. injection of MET (160 mg/kg body weight (1 mmol/kg)) or NaCl solution (control) in anesthetized rats. While the membrane potential measured under control conditions was similar to that in previous studies performed under similar conditions [20, 21] , MET signi¢cantly depolarized the liver cell membrane by about 6 mV ( Fig. 1 ).
In vitro experiments
Under in vitro conditions using superfused mouse liver slices, MET (0.5 mmol/l, 1 mmol/l) caused a concentration-dependent depolarization of the liver cell membrane by 5 mV (dV; 0.5 mmol/l) and 8 mV (1 mmol/l; Fig. 2A ). Superfusion with Krebs^Henseleit bicarbonate bu¡er which served as control did not a¡ect the membrane potential over time ( Fig.  2A) . MET's e¡ect became signi¢cant after 6^9 min from the start of superfusion and reached a plateau after 9 min ( Fig. 2A) . MET's e¡ect was at least partly reversible when switching back to superfusion with control solution (Fig. 2B) .
The depolarizing e¡ect of MET (1 mmol/l) was completely abolished under low Cl 3 conditions ([Cl 3 ] = 27 mmol/l; dV = 1 mV) and signi¢cantly reduced when the Cl 3 channel blocker NPPB (25 Wmol/l; dV = 3 mV) was added to the Krebs^Henseleit bicarbonate bu¡er (Fig. 3) . The blocker of the Na /K /2Cl 3 cotransporter bumetanide (100 Wmol/l in Krebs^Henseleit bu¡er) somewhat reduced the depolarizing e¡ect of metformin (dV = 4 mV; Fig. 3 ). As for low Cl 3 conditions and NPPB, bumetanide also reduced the basal membrane potential compared to normal Cl 3 , NPPB-free or bumetanide-free conditions ( Fig. 3) .
While MET's e¡ect on the liver cell membrane potential was reduced (dV = 4 mV vs. dV = 8 mV (P 6 0.05) 18 min after the start of superfusion) when using (bicarbonate-free) HEPES bu¡er instead of Krebs^Henseleit bicarbonate bu¡er, inhibition of carboanhydrase by acetazolamide (1 mmol/l in Krebs^Henseleit bicarbonate bu¡er; dV = 1 mV) or inhibition of the Cl 3 /HCO 3 3 exchanger by DIDS (100 Wmol/l in Krebs^Henseleit bicarbonate bu¡er; dV = 0 mV), which, however, also blocks Cl 3 channels, abolished its e¡ect (Fig. 4) . In contrast, neither blockade of K channels by Ba 2 (5 mmol/l), nor inhibition of the Na /K -ATPase by ouabain (1 mmol/l) or use of low Na superfusion bu¡er ([Na ] = 26 mmol/l) a¡ected the depolarization of the liver cell membrane induced by MET (1 mmol/l; Fig. 5 ).
Finally, while MET (1 mmol/l) depolarized the liver cell membrane and while glucagon (10 37 mol/l) hyperpolarized the liver cell membrane, co-superfusion of MET and glucagon left the membrane potential unchanged compared to control conditions (Fig. 6 ).
Discussion
The present study shows that metformin exerts a depolarizing e¡ect on the liver cell membrane both under in vivo and in vitro conditions. Under in vitro conditions, the depolarizing e¡ect of MET was observed at concentrations which are similar to therapeutic levels in portal blood (for review, see [23] ). The in vitro experiments further show that MET's e¡ect is at least partly reversible and that glucagon antagonized its e¡ect. MET's depolarizing e¡ect was absent when liver slices were superfused with low Cl 3 bu¡er, and was also absent in the presence of the Cl 3 channel blocker NPPB while the blocker of the Na / K /2Cl 3 cotransporter bumetanide had only a minor in£uence on MET's depolarizing e¡ect. Further, MET's e¡ect was also abolished by blockade of the carboanhydrase by acetazolamide and of the Cl 3 / HCO 3 3 exchanger by DIDS. Since DIDS also blocks hepatic Cl 3 channels [24] , its e¡ect might also partly be due to this action. Finally, MET's e¡ect was not in£uenced by BaCl 2 , by superfusion with low Na bu¡er or by the inhibitor of the Na /K -ATPase, ouabain.
The results provide evidence for the depolarizing e¡ect of MET on the liver cell membrane being mediated by an enhanced Cl 3 e¥ux from liver cells via Cl 3 channels. Further, MET's e¡ect depends on intracellular bicarbonate which, probably through the Cl 3 /HCO 3 3 exchanger importing Cl 3 in exchange for HCO 3 3 , is functionally coupled to Cl 3 e¥ux. The results also provide evidence that MET's depolarizing e¡ect on the liver cell membrane is independent of an in£uence on K or Na £uxes, the Na /K / 2Cl 3 cotransporter or the function of the Na /K -ATPase.
Interestingly, the depolarizing e¡ect of MET was only somewhat reduced when liver slices were superfused with nominally bicarbonate-free HEPES bu¡er. While at ¢rst sight this indicates that HCO 3 3 is only of minor importance for this e¡ect, MET's ef-fect was completely abolished during superfusion with Krebs^Henseleit bicarbonate bu¡er containing the carboanhydrase blocker acetazolamide. This clearly indicates that MET's depolarizing e¡ect depends on the intracellular formation of bicarbonate while extracellular bicarbonate seems to play only a minor role.
While intracellular and extracellular Cl 3 is generally supposed to distribute passively under steady state conditions depending on the liver cell membrane potential [25, 26] , an in£uence on Cl 3 £uxes, e.g. by MET, may a¡ect the liver cell membrane potential when the steady state equilibrium is disturbed. It is thus plausible that MET, by activating the Cl 3 /HCO 3 3 exchanger, disturbs the Cl 3 distribution across the plasma membrane and thus enhances Cl 3 e¥ux, leading to a depolarization of liver cells. A functional coupling between Cl 3 channels and the Cl 3 /HCO 3 3 exchanger has already been described in other cell types such as pancreatic duct cells [27] . The exact mechanism how MET a¡ects the Cl 3 /HCO 3 3 exchanger and Cl 3 channels is unknown. Since MET seems to exert its metabolic e¡ects at least in part at the cell membrane level by interfering with membrane £uidity and protein con¢guration [23] , it is plausible that its e¡ects on the liver cell membrane potential are also caused by in£uencing the Cl 3 / HCO 3 3 exchanger and/or Cl 3 channel function at the cell membrane level. Whether other agents having an e¡ect on Cl 3 channels also in£uence glucose production and/or gluconeogenesis is unknown to the authors.
We observed a lower baseline membrane potential when liver slices were superfused with HEPES bu¡er or with low Cl 3 HEPES bu¡er than with KrebsĤ enseleit bicarbonate bu¡er. This is in accordance with previous observations and may perhaps be related to a decrease in K conductance due to a decrease in intracellular pH [28, 29] .
The baseline membrane potential was also reduced when liver slices were superfused with Krebs^Henseleit bicarbonate bu¡er containing NPPB or bumetanide. While in the case of NPPB this may have been due to an inhibitory e¡ect of NPPB on K conductance [30] , the mechanism underlying bumetanide's e¡ect on the baseline membrane potential is not clear.
The depolarizing e¡ect of MET on the liver cell membrane may explain its inhibitory e¡ect on L-alanine uptake in liver cells which is thought to be at least partly responsible for the MET-induced inhibition of gluconeogenesis and hepatic glucose output [9^11]. Uptake of L-alanine into liver cells is mediated by an electrogenic Na -coupled transport mechanism [12^16] and depolarization of the liver cell membrane has been shown to reduce amino acid uptake [22] . Depolarization of the liver cell membrane through MET-stimulated Cl 3 e¥ux would reduce the driving force for electrogenic Na -coupled uptake of L-alanine and other gluconeogenic amino acids, e.g. glutamine [33] . Therefore, the MET-induced depolarization of the liver cell membrane could be directly responsible for at least part of the inhibition of gluconeogenesis from L-alanine through reduced L-alanine uptake into liver cells [9^11]. In this context, it was interesting to note that the depolarizing e¡ect of metformin, an agent which inhibits gluconeogenesis [1, 2] , was antagonized by glucagon, a pancreatic hormone which stimulates gluconeogenesis [31] and hyperpolarizes the liver cell membrane ( [17, 32] , and present study). This antagonism is most likely due to superposition of the e¡ects of MET and glucagon on the liver cell membrane potential.
In line with our hypothesis of an inhibition of L-alanine uptake into hepatocytes due to the depolarizing e¡ect of MET on liver cells, the glucagon induced hyperpolarization of liver cells seems to account for at least part of the increased rate of L-alanine uptake into liver cells and hence the glucagon stimulated gluconeogenesis from amino acids [10] . Apart from the antagonistic e¡ects of MET and glucagon on the uptake of gluconeogenic amino acids into liver cells and on gluconeogenesis, MET and glucagon also seem to exert opposite e¡ects on fat metabolism [1] .
Finally, while the control of the hepatic membrane potential by glucagon has been supposed to be related to cell volume regulation and cell metabolism (cell shrinking contributing to increased glycogenolysis, gluconeogenesis and proteolysis; see [18] ), it remains to be investigated whether the same also applies to MET, though with reversed premises.
The clinical relevance of the e¡ect of MET on the membrane voltage is underlined by the fact that the depolarizing e¡ect of MET was observed at concen-trations which are similar to therapeutic levels in portal blood (for review, see [23] ). Because L-alanine transport is enhanced in diabetes mellitus [34] and because increased gluconeogenesis is a metabolic hallmark in diabetes contributing to fasting and post-prandial hyperglycemia [35] , MET could antagonize these changes at their very base through its depolarizing e¡ect on the liver cell membrane, leading to reduced availability of L-alanine and other amino acids and thus a reduced rate of gluconeogenesis.
Since the uptake of conjugated bile acids into hepatocytes is mediated by an electrogenic Nacoupled transport mechanism and thus depends on the membrane voltage [36] , it remains to be investigated whether MET, by depolarizing the liver cell membrane, also a¡ects bile acid secretion and the electrogenic transport of other substances.
In summary, we have shown that MET depolarizes the liver cell membrane under in vivo and in vitro conditions. This e¡ect appears to be due to Cl 3 ef-£ux from liver cells being coupled to intracellular bicarbonate and an activation of the Cl 3 /HCO 3 3 exchanger by MET. MET's depolarizing e¡ect on the liver cell membrane could directly contribute to reduced electrogenic uptake of L-alanine and other amino acids in liver cells and thus MET's inhibitory e¡ect on gluconeogenesis.
